CLOs on the Move


 
Avvo is the largest online legal marketplace connecting consumers and lawyers. In Avvo`s Q&A forum, consumers can get their legal questions answered for free by more than 180,000 participating lawyers or search more than 6 million previously asked questions and answers. The lawyer directory provides Avvo-rated profiles, client reviews, and peer endorsements for 97 percent of all lawyers in the U.S., so consumers can find the lawyer who`s right for them. Avvo also helps lawyers grow their businesses with marketing tools and services including Avvo Ignite, a cloud-based marketing platform designed specifically for attorneys. Avvo and Avvo Ignite are ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.avvo.com
  • 1501 4th Avenue Suite 1900
    Seattle, WA USA 98101
  • Phone: 206.734.4111

Executives

Name Title Contact Details
Carlos Longoria
Currently providing General Counsel Profile
Josh King
General Counsel Profile

Similar Companies

n-Tech Solutions Inc

n-Tech Solutions Inc is a Columbia, MD-based company in the Software and Internet sector.

Game Plan

Game Plan is a software platform that helps athletics organizations deliver online education, mentorship and career services.

When I Work

When I Work is a market leader in hourly workforce management that provides businesses a fully integrated scheduling, time tracking and team messaging solution. Trusted by over 150,000 workplaces worldwide, When I Work ensures reliable shift coverage, engaged employees, and faster decisions — giving everybody what they need to be successful at work. Managing, scheduling, and coordinating hourly teams is time-consuming, complicated, and expensive. Back office spreadsheets and disjointed systems have plagued hourly workplaces for decades — resulting in high labor costs, painful inefficiency and employee turnover. When I Work changes everything with integrated scheduling, time tracking, and team messaging. It`s a complete employee management solution that ensures reliable shift coverage, engaged employees, and faster decisions.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.

Pedigree Technologies

We solve business problems using award winning Machine to Machine (M2M) technology supporting Condition-based Service Management (CbSM) practices.